Global Biologics CDMO Market
Pharmaceuticals

Comprehensive Biologics CDMO Market Analysis 2024: Size, Share, And Key Trends

Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What is the Expected Growth Rate of the Biologics CDMO Market from 2024 to 2033?

The biologics CDMO market has rapidly grown, anticipated to rise from $18.44 billion in 2023 to $21.30 billion in 2024 with a CAGR of 15.4%. Growth drivers include increased biologics development, cost efficiency, a focus on core competencies, regulatory compliance, and the globalization of pharmaceutical supply chains.

The biologics CDMO market is projected to experience significant growth, reaching $36.54 billion by 2028 at a CAGR of 14.4%. This growth is attributed to the demand for biologic therapies, biosimilars, and investments in biomanufacturing. Key trends will include the expansion of capabilities and the adoption of single-use technologies.

Claim Your Free Sample of the Global Biologics CDMO Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=14056&type=smp

What Key Factors Are Fueling the Growth of the Biologics CDMO Market?

The rising demand for cell and genetic therapy is anticipated to drive the biologic CDMO market. These therapies utilize living cells or genetic material to treat diseases. The demand for such therapies is increasing due to their innovative approaches. Biologic CDMOs provide expertise in producing cell and gene therapies. The American Society of Gene & Cell Therapy reported a 7% growth in the therapy pipeline in 2022, reaching 3,726 therapies. Therefore, the demand for cell and genetic therapy is driving the biologic CDMO market.

What Are the Major Segments of the Biologics CDMO Market?

1) By Cell Type: Mammalian, Non-Mammalian

2) By Product Type: Biologics, Biosimilars

What New Trends Are Transforming the Biologics CDMO Market?

Major companies in the biologics CDMO market are advancing solutions like new cell lines to enhance biopharmaceutical development. In November 2023, Lonza Group launched GS Effex cell lines, producing antibodies that are fucose-free and demonstrate increased potency for immunotherapy applications.

Order Now for Fast Delivery of Your Biologics CDMO Market Report!

https://www.thebusinessresearchcompany.com/report/biologics-cdmo-global-market-report

Which Regions Are Driving Growth in the Biologics CDMO Market?

North America was the largest region in the biologics CDMO market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biologics CDMO market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Biologics CDMO Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the biologics cdmo market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Biologics CDMO Market Include

1. Biologics CDMO Market Executive Summary

2. Biologics CDMO Market Segments

3. Biologics CDMO Market Size And Template Market Growth Rate

4. Key Biologics CDMO Market Trends

5. Major Biologics CDMO Market Drivers

……

25. Key Mergers And Acquisitions In The Biologics CDMO Market

26. Top Biologics CDMO Companies

27. Biologics CDMO Market Opportunities And Strategies

28. Biologics CDMO Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

Biodegradable Plastics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/biodegradable-plastics-global-market-report

Soap And Other Detergents Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/soap-and-other-detergents-global-market-report

Detergent Chemicals Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/detergent-chemicals-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Leave a Reply

Your email address will not be published. Required fields are marked *